What You Need to Know About Roundup and Non-Hodgkin’s Lymphoma
Roundup has generated billions of dollars in revenue for Monsanto. While the product has been around since the 1970s, it really took off in the 1990s when the company created genetically engineered crops that can resist Roundup. That allowed farmers to use as much of the weed killer as they wanted without having to worry about damaging their crops. But this product has a dark side, as it has been linked to a type of cancer known as non-Hodgkin’s lymphoma.
What’s the Problem?
The link between Roundup and non-Hodgkin’s lymphoma is due to glyphosate, the active chemical found in the product. A growing amount of evidence shows that people exposed to Roundup are at a higher risk of being diagnosed with the disease. Monsanto claims glyphosate is harmless, but plaintiffs in lawsuits against the company claim otherwise.
There are a lot of scientists who say Roundup can cause non-Hodgkin’s lymphoma, including researchers working on behalf of the World Health Organization and many others. Researchers at the Massachusetts Institute of Technology (MIT) stated that glyphosate could induce disease and disrupt normal bodily functions.
While many researchers state Roundup is a carcinogen, many others say it isn’t. But recently released court documents cast serious doubt on the validity of those who say Roundup doesn’t cause cancer. Among the documents are internal Monsanto e-mails from executives stating that the company could “ghostwrite” glyphosate research on behalf of academics. Monsanto would write the research, according to the documents, and the academics would simply edit them and sign their names.
As you can imagine, this raises all kinds of red flags regarding the integrity of pro-glyphosate research.